PDC4S:\Health\MKSAP 18 Internal Medicine Audio Companion Part A\06 Rheumatology

Up one directory...
NameSizeDate Modified
01-01 Introduction to Rheumatology Section.mp37,034 KB9/18/2018 9:42 AM
01-02 Approach to the Patient with Rheumatologic Disease.mp36,662 KB9/18/2018 9:42 AM
01-03 The Musculoskeletal Examination.mp32,872 KB9/18/2018 9:42 AM
01-04 Session MCQ Item 20 An 85-year-old Woman is Evaluated for Left Knee Pain.mp32,957 KB9/18/2018 9:42 AM
01-05 Arthritis.mp311,470 KB9/18/2018 9:42 AM
01-06 Extra-Articular Manifestations of Rheumatologic Disease.mp34,126 KB9/18/2018 9:42 AM
01-07 Session MCQ Item 28 A 43-year-old Woman has Left Knee Pain and Swelling.mp33,805 KB9/18/2018 9:42 AM
01-08 Dermatologic Manifestations of Rheumatologic Disease.mp315,041 KB9/18/2018 9:42 AM
01-09 Ocular Manifestations of Systemic Inflammatory Disease.mp33,681 KB9/18/2018 9:42 AM
01-10 Internal Organ Involvement.mp37,977 KB9/18/2018 9:42 AM
01-11 Laboratory Studies.mp37,914 KB9/18/2018 9:42 AM
01-12 Session 1 Key Points.mp31,145 KB9/18/2018 9:42 AM
01-13 Close to Session 1.mp3458 KB9/18/2018 9:42 AM
02-01 Introduction to Session 2.mp3614 KB9/18/2018 9:42 AM
02-02 Complement and Autoantibody Tests.mp39,278 KB9/18/2018 9:42 AM
02-03 Autoantibodies in Rheumatologic Disease.mp38,524 KB9/18/2018 9:42 AM
02-04 Session MCQ Item 35 A 73-year-old Woman is Evaluated for Osteoarthritis.mp34,103 KB9/18/2018 9:42 AM
02-05 Imaging Studies.mp311,880 KB9/18/2018 9:42 AM
02-06 Joint Aspiration.mp33,086 KB9/18/2018 9:42 AM
02-07 Principles of Therapeutics.mp33,175 KB9/18/2018 9:42 AM
02-08 NSAIDs.mp39,396 KB9/18/2018 9:42 AM
02-09 Session MCQ Item 37 A 49-year-old Woman is Evaluated for Worsening Joint Symptoms.mp34,386 KB9/18/2018 9:42 AM
02-10 Colchicine.mp33,663 KB9/18/2018 9:42 AM
02-11 Analgesics and Pain Pathway Modulators.mp37,260 KB9/18/2018 9:42 AM
02-12 Session 2 Key Points.mp32,881 KB9/18/2018 9:42 AM
02-13 Close to Session 2.mp3551 KB9/18/2018 9:42 AM
03-01 Introduction to Session 3.mp3634 KB9/18/2018 9:42 AM
03-02 Disease-Modifying Antirheumatic Drugs.mp312,915 KB9/18/2018 9:42 AM
03-03 Nonbiologic DMARDs.mp39,298 KB9/18/2018 9:42 AM
03-04 Session MCQ Item 40 A 21-year-old Woman is Evaluated for Worsening Rash and Arthritis.mp32,958 KB9/18/2018 9:42 AM
03-05 Biologic DMARDs.mp35,110 KB9/18/2018 9:42 AM
03-06 Other Biologic Disease-Modifying Antirheumatic Drugs.mp312,162 KB9/18/2018 9:42 AM
03-07 Session MCQ Item 42 A 32-year-old Woman is Evaluated for Dry Eyes and Dry Mouth.mp34,254 KB9/18/2018 9:42 AM
03-08 Urate-Lowering Therapy.mp310,097 KB9/18/2018 9:42 AM
03-09 Rheumatologic Medications and Pregnancy.mp38,410 KB9/18/2018 9:42 AM
03-10 Vaccination and Screening in Immunosupression.mp32,591 KB9/18/2018 9:42 AM
03-11 Session 3 Key Points.mp32,689 KB9/18/2018 9:42 AM
03-12 Close to Session 3.mp3645 KB9/18/2018 9:42 AM
04-01 Introduction to Session 4.mp3626 KB9/18/2018 9:42 AM
04-02 Nonpharmacologic Measures To Address Pain.mp35,854 KB9/18/2018 9:42 AM
04-03 Rheumatoid Arthritis.mp311,303 KB9/18/2018 9:42 AM
04-04 Diagnosis.mp37,666 KB9/18/2018 9:42 AM
04-05 Session MCQ Item 43 A 67-year-old Woman is Seen for Severe Rheumatoid Arthritis.mp33,915 KB9/18/2018 9:42 AM
04-06 Consequences of Persistent Inflammation.mp35,127 KB9/18/2018 9:42 AM
04-07 Laboratory and Imaging Studies.mp36,153 KB9/18/2018 9:42 AM
04-08 Complications and Extra-Articular Manifestations.mp310,016 KB9/18/2018 9:42 AM
04-09 Session MCQ Item 54 A 30-year-old Woman is Evaluated for Pain and Swelling of the PIP Joints.mp34,284 KB9/18/2018 9:42 AM
04-10 Management.mp34,386 KB9/18/2018 9:42 AM
04-11 Disease-Modifying Antirheumatic Drugs.mp36,909 KB9/18/2018 9:42 AM
04-12 Session 4 Key Points.mp33,098 KB9/18/2018 9:42 AM
04-13 Close to Session 4.mp3532 KB9/18/2018 9:42 AM
05-01 Introduction to Session 5.mp3621 KB9/18/2018 9:42 AM
05-02 Pathophysiology of Osteoarthritis.mp37,234 KB9/18/2018 9:42 AM
05-03 Classification.mp36,938 KB9/18/2018 9:42 AM
05-04 Session MCQ Item 64 A 55-year-old Man is Evaluated for Progressive Joint Pain.mp33,597 KB9/18/2018 9:42 AM
05-05 Diffuse Idiopathic Skeletal Hyperostosis.mp33,689 KB9/18/2018 9:42 AM
05-06 Diagnosis.mp35,412 KB9/18/2018 9:42 AM
05-07 Laboratory and Imaging Studies.mp36,856 KB9/18/2018 9:42 AM
05-08 Session MCQ Item 75 A 53-year-old Woman is Evaluated for Sensory Loss in the Hands.mp33,295 KB9/18/2018 9:42 AM
05-09 Management.mp33,940 KB9/18/2018 9:42 AM
05-10 Pharmacologic Therapy.mp38,904 KB9/18/2018 9:42 AM
05-11 Fybromyalgia.mp38,349 KB9/18/2018 9:42 AM
05-12 Management.mp36,357 KB9/18/2018 9:42 AM
05-13 Session 5 Key Points.mp33,640 KB9/18/2018 9:42 AM
05-14 Close to Session 5.mp3639 KB9/18/2018 9:42 AM
06-01 Introduction to Session 6.mp3412 KB9/18/2018 9:42 AM
06-02 Spondyloarthritis.mp37,038 KB9/18/2018 9:42 AM
06-03 Classification of Spondyloarthritis.mp36,369 KB9/18/2018 9:42 AM
06-04 Session MCQ Item 88 A 40-year-old Woman is Evaluated for Inflammatory Arthritis.mp32,711 KB9/18/2018 9:42 AM
06-05 Ankylosing Spondylitis and Psoriatic Arthritis.mp312,756 KB9/18/2018 9:42 AM
06-06 Inflammatory Bowel Disease-Related Arthritis.mp38,562 KB9/18/2018 9:42 AM
06-07 Diagnosis.mp311,736 KB9/18/2018 9:42 AM
06-08 Session MCQ Item 95 A 48-year-old Man is Evaluated for Gout.mp33,223 KB9/18/2018 9:42 AM
06-09 Management.mp39,054 KB9/18/2018 9:42 AM
06-10 Session 6 Key Points.mp34,025 KB9/18/2018 9:42 AM
06-11 Close to Session 6.mp3419 KB9/18/2018 9:42 AM
07-01 Introduction to Session 7.mp3405 KB9/18/2018 9:42 AM
07-02 Systemic Lupus Erythematosis.mp37,615 KB9/18/2018 9:42 AM
07-03 Clinical Manifestations.mp39,573 KB9/18/2018 9:42 AM
07-04 Kidney Involvement.mp36,503 KB9/18/2018 9:42 AM
07-05 Cardiovascular and Pulmonary Involvement.mp35,807 KB9/18/2018 9:42 AM
07-06 Hematologic and Gastrointestinal Involvement.mp37,646 KB9/18/2018 9:42 AM
07-07 Association with Malignancy.mp31,491 KB9/18/2018 9:42 AM
07-08 Diagnosis.mp37,277 KB9/18/2018 9:42 AM
07-09 Laboratory Studies.mp35,052 KB9/18/2018 9:42 AM
07-10 Differential Diagnosis.mp36,807 KB9/18/2018 9:42 AM
07-11 Management.mp38,394 KB9/18/2018 9:42 AM
07-12 Session 7 Key Points.mp33,509 KB9/18/2018 9:42 AM
07-13 Close to Session 7.mp3416 KB9/18/2018 9:42 AM
08-01 Introduction to Session 8.mp3619 KB9/18/2018 9:42 AM
08-02 Pregnancy and Childbirth Issues.mp310,244 KB9/18/2018 9:42 AM
08-03 Sjogren Syndrome.mp37,429 KB9/18/2018 9:42 AM
08-04 Diagnosis of Sjogrens Syndrome.mp36,905 KB9/18/2018 9:42 AM
08-05 Management.mp34,780 KB9/18/2018 9:42 AM
08-06 Inflammatory Myopathies.mp311,951 KB9/18/2018 9:42 AM
08-07 Epidemiology and Pathophysiology of Inflammatory Myopathies.mp32,587 KB9/18/2018 9:42 AM
08-08 Polymyositis.mp34,691 KB9/18/2018 9:42 AM
08-09 Dermatomyositis.mp39,975 KB9/18/2018 9:42 AM
08-10 Inflammatory Myopathies and Malignancy.mp32,346 KB9/18/2018 9:42 AM
08-11 Diagnosis.mp34,852 KB9/18/2018 9:42 AM
08-12 Session 8 Key Points.mp33,443 KB9/18/2018 9:42 AM
08-13 Close to Session 8.mp3624 KB9/18/2018 9:42 AM
09-01 Introduction to Session 9.mp3636 KB9/18/2018 9:42 AM
09-02 Imaging.mp34,878 KB9/18/2018 9:42 AM
09-03 Management and Prognosis.mp36,774 KB9/18/2018 9:42 AM
09-04 Systemic Sclerosis.mp38,841 KB9/18/2018 9:42 AM
09-05 Common Features of the Scleroderma Spectrum Disorders.mp310,171 KB9/18/2018 9:42 AM
09-06 Clinical Manifestations and Diagnosis.mp34,913 KB9/18/2018 9:42 AM
09-07 Cutaneous Involvement.mp34,971 KB9/18/2018 9:42 AM
09-08 Musculoskeletal Involvement.mp33,824 KB9/18/2018 9:42 AM
09-09 Vascular Involvement.mp34,980 KB9/18/2018 9:42 AM
09-10 Kidney and Lung Involvement.mp38,893 KB9/18/2018 9:42 AM
09-11 Session 9 Key Points.mp33,683 KB9/18/2018 9:42 AM
09-12 Close to Session 9.mp3662 KB9/18/2018 9:42 AM
10-01 Introduction to Session 10.mp3632 KB9/18/2018 9:42 AM
10-02 Management.mp39,549 KB9/18/2018 9:42 AM
10-03 ACE Inhibitors.mp37,388 KB9/18/2018 9:42 AM
10-04 Mixed Connective Tissue Disease.mp33,944 KB9/18/2018 9:42 AM
10-05 Comparison of MCTD, UCT and Overlap Syndromes.mp33,674 KB9/18/2018 9:42 AM
10-06 Clinical Manifestations and Diagnosis.mp32,376 KB9/18/2018 9:42 AM
10-07 Crystal Arthropathies.mp34,248 KB9/18/2018 9:42 AM
10-08 Epidemiology and Pathophysiology of Gout.mp33,375 KB9/18/2018 9:42 AM
10-09 Causes of Hyperuricemia.mp35,340 KB9/18/2018 9:42 AM
10-10 Acute Gouty Arthritis.mp38,339 KB9/18/2018 9:42 AM
10-11 Intercritical Gout.mp33,484 KB9/18/2018 9:42 AM
10-12 Chronic Recurrent and Tophaceous Gout.mp35,302 KB9/18/2018 9:42 AM
10-13 Diagnosis.mp34,238 KB9/18/2018 9:42 AM
10-14 Pseudogout.mp39,067 KB9/18/2018 9:42 AM
10-15 Session 10 Key Points.mp31,150 KB9/18/2018 9:42 AM
10-16 Close to Session 10.mp3643 KB9/18/2018 9:42 AM
11-01 Introduction to Session 11.mp3642 KB9/18/2018 9:42 AM
11-02 Management of Gout.mp313,767 KB9/18/2018 9:42 AM
11-03 Urate-Lowering Therapy.mp313,854 KB9/18/2018 9:42 AM
11-04 Calcium Pyrophosphate Deposition.mp35,223 KB9/18/2018 9:42 AM
11-05 Clinical Manifestations and Diagnosis.mp35,399 KB9/18/2018 9:42 AM
11-06 Management.mp35,771 KB9/18/2018 9:42 AM
11-07 Infectious Arthritis.mp33,211 KB9/18/2018 9:42 AM
11-08 Laboratory and Imaging Studies.mp35,601 KB9/18/2018 9:42 AM
11-09 Infection with Gram-Positive Organisms.mp35,724 KB9/18/2018 9:42 AM
11-10 Disseminated Gonococcal Infection.mp36,763 KB9/18/2018 9:42 AM
11-11 Session 11 Key Points.mp33,241 KB9/18/2018 9:42 AM
11-12 Close to Session 11.mp3638 KB9/18/2018 9:42 AM
12-01 Introduction to Session 12.mp3630 KB9/18/2018 9:42 AM
12-02 Mycobacterium Tuberculosis.mp36,801 KB9/18/2018 9:42 AM
12-03 Viral Infections.mp36,095 KB9/18/2018 9:42 AM
12-04 Parvovirus B19.mp34,838 KB9/18/2018 9:42 AM
12-05 Prosthetic Joint Infections.mp34,615 KB9/18/2018 9:42 AM
12-06 Management.mp311,218 KB9/18/2018 9:42 AM
12-07 Systemic Vasculitis.mp39,228 KB9/18/2018 9:42 AM
12-08 Giant Cell Arteritis.mp39,116 KB9/18/2018 9:42 AM
12-09 Management.mp35,374 KB9/18/2018 9:42 AM
12-10 Polymyalgia Rheumatica.mp34,294 KB9/18/2018 9:42 AM
12-11 Takayasu Arteritis.mp34,249 KB9/18/2018 9:42 AM
12-12 Session 12 Key Points.mp32,969 KB9/18/2018 9:42 AM
12-13 Close to Session 12.mp3534 KB9/18/2018 9:42 AM
13-01 Introduction to Session 13.mp3624 KB9/18/2018 9:42 AM
13-02 Polyarteritis Nodosa.mp39,395 KB9/18/2018 9:42 AM
13-03 Primary Angiitis of the Central Nervous System.mp35,636 KB9/18/2018 9:42 AM
13-04 Kawasaki Disease.mp32,681 KB9/18/2018 9:42 AM
13-05 ANCA-Associated Vasculitis.mp35,291 KB9/18/2018 9:42 AM
13-06 Clinical Features of ANCA-Associated Vasculitis Disease.mp311,587 KB9/18/2018 9:42 AM
13-07 Granulomatosis with Polyangiitis.mp34,897 KB9/18/2018 9:42 AM
13-08 Microscopic Polyangiitis.mp32,451 KB9/18/2018 9:42 AM
13-09 Eosiophilic Granulomatosis with Polyangiitis.mp34,696 KB9/18/2018 9:42 AM
13-10 Immune Complex-Mediated Vasculitis.mp33,865 KB9/18/2018 9:42 AM
13-11 Cryoglobulinemic Vasculitis.mp37,398 KB9/18/2018 9:42 AM
13-12 IgA Vasculitis and Hypersensitivity Vasculitis.mp34,554 KB9/18/2018 9:42 AM
13-13 Session 13 Key Points.mp33,093 KB9/18/2018 9:42 AM
13-14 Close to Session 13.mp3641 KB9/18/2018 9:42 AM
14-01 Introduction to Session 14.mp3408 KB9/18/2018 9:42 AM
14-02 Other Rheumatologic Diseases.mp37,622 KB9/18/2018 9:42 AM
14-03 Relapsing Polychondritis.mp33,523 KB9/18/2018 9:42 AM
14-04 Adult-Onset Still Disease.mp35,786 KB9/18/2018 9:42 AM
14-05 Autoinflammatory Disease.mp312,855 KB9/18/2018 9:42 AM
14-06 Sarcoidosis.mp35,780 KB9/18/2018 9:42 AM
14-07 Genetic Diseases of Connective Tissue.mp311,559 KB9/18/2018 9:42 AM
14-08 IgG4-Related Disease.mp310,062 KB9/18/2018 9:42 AM
14-09 Session 14 Key Points.mp32,418 KB9/18/2018 9:42 AM
14-10 Close to Rheumatology Section.mp31,291 KB9/18/2018 9:42 AM